Royal Sense Limited (BSE: 544143) is a New Delhi, Delhi-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹39 Cr, it ranks #3,977 by market cap among the 6,197 Indian listed companies on FinBizNet, and #9 of 13 in Pharmaceutical Product Distribution. At ₹69.00 (as of 16 Nov 2026), the share price is 72.4% below its 52-week high of ₹250.45 and 4.6% above its 52-week low of ₹65.95. The share price is down 71.2% over one year and down 31.0% over three months.
| Current Price | ₹69.00 |
|---|---|
| Market Cap | ₹39 Cr |
| BSE Code | 544143 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| P/E Ratio | 5.6 |
| Return on Assets | 14.10% |
| 52-Week Range | ₹65.95 – ₹250.45 |
| 1-Year Price Change | -71.2% |
| 3-Month Price Change | -31.0% |
| Beta (1Y) | 0.9 |
| Headquarters | New Delhi, Delhi |
| Website | www.royalsense.in |
Delivery averaged 100.0% of traded volume across 11 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Royal Sense Limited engages in supplying various surgical accessories, tools, equipment, and other pharmaceutical products under the STERGIC brand name. It offers medical equipment, surgical instruments and consumables, laboratory equipment and reagents, medical consumables, diagnostics tools, sanitary products, pharmaceuticals, medicine, and cosmetics, as well as disposables. The company serves hospitals, laboratories, institutions, and clinics. Royal Sense Limited was founded in 2015 and is based in New Delhi, India.
1. Surgical & Medical Equipment-This segment engages in the wholesale of medical equipment products. 2. NA-NA 3. NA-NA 4. NA-NA
1. Surgical & Medical Equipment-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Royal Sense Limited | ₹39 Cr | 5.6 | — | — | -71.2% |
Listed by market capitalisation. Ratios are shown for context only.
Royal Sense Limited is trading at ₹69.00, with a market capitalisation of ₹39 Cr.
Royal Sense Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Royal Sense Limited has a P/E of 5.6.
Royal Sense Limited is listed on the BSE under the scrip code 544143.
Royal Sense Limited's share price is down 71.2% over one year and down 31.0% over three months. Its 52-week range is ₹65.95 to ₹250.45.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.